FDA Approved: MEPSEVII — Supplemental Application (Ultragenyx Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Mepsevii (vestronidase alfa) submitted by Ultragenyx Pharmaceutical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Vii

Drugs mentioned

• Mepsevii (vestronidase alfa)

Snippet

SUPPL AP for MEPSEVII (VESTRONIDASE ALFA)